You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T-ALL/LBL

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T-lymphoblastic Lymphoma, T-ALL Trial in Shanghai (CAR-T)

Recruiting
  • T-lymphoblastic Lymphoma
  • T-ALL
  • CAR-T
  • Shanghai, China
    Shanghai Ruijin Hospital
Nov 14, 2023

Cytarabine+Thiotepa + Fludarabine + Busulfan, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial in Hangzhou

Recruiting
  • Cytarabine+Thiotepa + Fludarabine + Busulfan
  • T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
  • cytarabine+thiotepa+ fludarabine + busulfan
  • Hangzhou, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Oct 26, 2022

T-cell Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Australia, United States (WU-CART-007)

Recruiting
  • T-cell Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • WU-CART-007
  • Duarte, California
  • +7 more
Jun 22, 2022

Leukemia, T Cell Trial in Beijing (CD7 CART)

Recruiting
  • Leukemia, T Cell
  • CD7 CART
  • Beijing, Hebei, China
    He bei Yan da Lu dao pei Hospital
May 24, 2022

Tumors, Hematologic Tumors, Hematologic Diseases Trial in Hefei (RD13-02 cell infusion)

Recruiting
  • Neoplasms
  • +2 more
  • RD13-02 cell infusion
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Jun 5, 2023

Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)

Recruiting
  • Neoplasms
  • +2 more
  • RD13-02 cell infusion
  • Xuzhou, Jiangsu, China
    Affiliated hospital of Xuzhou medical college
Jun 7, 2023

Tumors, Hematologic Tumors, Tumors by Site Trial in Hangzhou (RD13-02 cell infusion)

Recruiting
  • Neoplasms
  • +3 more
  • RD13-02 cell infusion
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Feb 6, 2023

T-cell Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma Trial in Kunming (Target CD7 CAR-T cells)

Withdrawn
  • T-cell Acute Lymphoblastic Leukemia
  • T-lymphoblastic Lymphoma
  • Target CD7 CAR-T cells
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Nov 23, 2022

Leukemia, Lymphoblastic, Leukemia Trial in Houston (CB-103, Venetoclax)

Not yet recruiting
  • Leukemia, Lymphoblastic
  • Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
Jul 19, 2022

T-cell Acute Lymphoblastic Leukemia/Lymphoma Trial in Beijing (Senl-T7)

Recruiting
  • T-cell Acute Lymphoblastic Leukemia/Lymphoma
  • Senl-T7
  • Beijing, Hebei, China
    Hebei yanda Hospital
Nov 22, 2022

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Trial (Cladribine)

Not yet recruiting
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
  • (no location specified)
Dec 17, 2020

T-cell Type Acute Leukemia-Precursor, T-lymphoblastic Lymphoma/Leukaemia Trial in Worldwide (Isatuximab SAR650984,

Terminated
Has Results
  • T-cell Type Acute Leukemia-Precursor
  • T-lymphoblastic Lymphoma/Leukaemia
  • Isatuximab SAR650984
  • +4 more
  • Atlanta, Georgia
  • +16 more
Mar 10, 2022

T Cell Lymphoblastic Lymphoma Trial in Beijing (BT-007 CD7 CAR-T cells)

Recruiting
  • T Cell Lymphoblastic Lymphoma
  • BT-007 CD7 CAR-T cells
  • Beijing, China
    Beijing Cancer Hospital
Sep 22, 2022

T Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma Trial in Langfang (RD13-01 cell infusion)

Unknown status
  • T Acute Lymphoblastic Leukemia
  • T-lymphoblastic Lymphoma
  • RD13-01 cell infusion
  • Langfang, Hebei, China
    Hebei Yanda Ludaopei Hospital
Nov 3, 2020

T-cell Lymphoblastic Lymphoma Trial in Shanghai, Chengdu (Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine,

Not yet recruiting
  • T-cell Lymphoblastic Lymphoma
  • Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin
  • Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide
  • Shanghai, Shanghai, China
  • +1 more
Dec 27, 2022

T Acute Lymphoblastic Leukemia, Early T Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma Trial in Italy (bone marrow

Recruiting
  • T Acute Lymphoblastic Leukemia
  • +3 more
  • bone marrow and/or peripheral blood samples withdrawal
  • Ancona, Italy
  • +9 more
Nov 24, 2022

Induction Chemo, Acute T-Lymphocytic Leukemia, T-cell Lymphoblastic Lymphoma Leukemia Trial in Suzhou (Decitabine combined with

Recruiting
  • Induction Chemotherapy
  • +3 more
  • Decitabine combined with HAAG Regimen
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jun 22, 2020

Acute Lymphoblastic Leukemia, Lymphoblastic Leukemia Trial in Canada, United States (IM JZP-458, IV JZP-458)

Completed
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Leukemia
  • IM JZP-458
  • IV JZP-458
  • Birmingham, Alabama
  • +73 more
Aug 3, 2022

B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Azacitidine Injection
  • +2 more
  • (no location specified)
Oct 15, 2023

Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (BEAM-201)

Recruiting
  • Lymphoblastic Lymphoma
  • +2 more
  • BEAM-201
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jun 2, 2023

T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

Not yet recruiting
  • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
  • CD7-CART01
  • (no location specified)
Sep 26, 2023

T-cell Acute Lymphoblastic Leukemia, Lymphoblastic T-Cell Lymphoma Trial in Barcelona (CD1a-CAR T)

Not yet recruiting
  • T-cell Acute Lymphoblastic Leukemia
  • Lymphoblastic T-Cell Lymphoma
  • CD1a-CAR T
  • Barcelona, Spain
  • +1 more
Jan 10, 2023

T-Cell Acute Lymphocytic Leukemia Trial in Langfang (CD7 CAR-T)

Recruiting
  • T-Cell Acute Lymphocytic Leukemia
  • CD7 CAR-T
  • Langfang, Hebei, China
    Hebei Yanda Hospital
Jun 26, 2023

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial (Asparaginase Erwinia Chrysanthemi (recombinant))

Approved for marketing
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Asparaginase Erwinia Chrysanthemi (recombinant)
  • (no location specified)
Jul 27, 2021

Leukemia, Acute Lymphoblastic Leukemia Trial in New York (gene-modified T cells targeted)

Active, not recruiting
  • Leukemia
  • Acute Lymphoblastic Leukemia
  • gene-modified T cells targeted
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 1, 2023